Results 51 to 60 of about 330,546 (163)

MAFLD and chronic kidney disease: two sides of the same coin?

Hepatology International, 2023
Ziyang Pan, S. Alqahtani, M. Eslam
semanticscholar   +1 more source

Aterosclerosis y afectación de la función cognitiva Atherosclerosis and cognitive function impairment

Revista Cubana de Investigaciones Biomédicas, 2012
La aterosclerosis es un proceso de origen multicausal y se acompaña de una gran variedad de manifestaciones clínicas y humorales. Son conocidos los factores de riesgo aterogénicos como dislipidemias, hipertensión arterial, diabetes mellitus, obesidad ...
Regino Piñeiro Lamas, José Emilio Fernández-Britto Rodríguez, Ivo Gómez Padrón   +2 more
doaj  

Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders

Journal of Lipid Research, 1997
Peroxisomal disorders arise either from defects in the biogenesis of peroxisomes or from the defective synthesis of one or more peroxisomal enzymes. These defects result in metabolic disturbances in peroxisomal beta-oxidation of various fatty acids and ...
Y Y van der Hoek, R J Wanders, A E van den Ende, H G Kraft, B R Gabel, J J Kastelein, M L Koschinsky   +6 more
doaj  

Plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro- and Cardiovascular Diseases in the Metabolic Syndrome [PDF]

, 2015
Kazushi Tsuda
openalex   +1 more source

Preventive cytoprotection in social diseases

Терапевтический архив, 2015
Among many cytoprotective drugs, only a few of them that have a targeted metabolic effect include agents that partially inhibit oxidation of free fatty acids, the so-called p-FOX inhibitors (partial fatty acid oxidation inhibitors). Aim.
A S Skotnikov, G N Gorokhovskaya, A M Shilov, V L Yun, M A Khamurzova   +4 more
doaj  

Cirrosis y encefalopatía hepáticas: consecuencias clínico-metabólicas y soporte nutricional Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support

Nutrición Hospitalaria, 2008
La cirrosis representa el estadio final de muchas enfermedades crónicas del hígado y se asocia con malnutrición en mayor o menor grado, con independencia de su etiología, sobre todo en los estadios avanzados.
A. Mesejo, M. Juan, A. Serrano
doaj  

Marcadores inflamatórios e anticorpos anti-chlamydia em pacientes com síndrome metabólica Marcadores inflamatorios y anticuerpos anti-chlamydia en pacientes con síndrome metabólico Inflammatory markers and antichlamydial antibodies in patients with metabolic syndrome

Arquivos Brasileiros de Cardiologia, 2011
FUNDAMENTO: A síndrome metabólica está associada ao aumento de risco de eventos cardiovasculares. Marcadores inflamatórios e anticorpos anti-Chlamydia têm sido relacionados ao desenvolvimento e à progressão da aterosclerose e dos eventos cardiovasculares.
Rosecler Riethmuller Franco, Luiz Carlos Bodanese, Giuseppe Repetto, Jacqueline da Costa Escobar Piccoli, Mario Wiehe, Cassiane Bonato, Marta Maria Medeiros Frescura Duarte, Thiago Duarte   +7 more
doaj  

Oral Presentation

European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Burning fuels burns the brain's bioenergetic bridges: On the importance of physiological resilience. [PDF]

Exp Physiol, 2023
Sixtus RP, Bailey DM.
europepmc   +1 more source

The Importance of Management of Obesity Disease and Metabolic Syndrome for the Prevention of Cerebro-Cardiovasucular Disease

, 2018
Shigeru Miyazaki
openalex   +2 more sources